TMCnet News
Research and Markets: Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/jftw6h/oppositional) has announced the addition of the "Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014" report to their offering. Our clinical trial report, Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2014" provides data on the Oppositional Defiant Disorder (ODD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oppositional Defiant Disorder (ODD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oppositional Defiant Disorder (ODD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. Scope
Reasons to buy
For more information visit http://www.researchandmarkets.com/research/jftw6h/oppositional
|